论文部分内容阅读
目的:观察肾炎康复片联合氯沙坦钾治疗Ig A肾病的临床疗效。方法:将40例Ig A肾病患者随机分为两组各20例,对照组采用氯沙坦钾治疗,治疗组在对照组治疗基础上加肾炎康复片治疗。观察两组治疗前后尿常规中潜血、红细胞(高倍视野)个数、红细胞计数、24h尿蛋白定量等。结果:总有效率治疗组为85.0%,对照组为70.0%,组间比较,差异有统计学意义(P<0.05);两组尿常规及实验室各项检测指标治疗前后组内比较及治疗后组间比较,差异均有统计学意义(P<0.05,P<0.01)。结论:肾炎康复片联合氯少坦钾治疗Ig A肾病有较好疗效。
Objective: To observe the clinical effect of nephritis kang tablet and losartan potassium on Ig A nephropathy. Methods: Forty patients with IgA nephropathy were randomly divided into two groups of 20 cases. The control group was treated with losartan potassium. The treatment group was treated with Shenyinkang tablets based on the control group. Before and after treatment in the two groups observed urine occult blood, the number of red blood cells (high power field), red blood cell count, 24h urinary protein and so on. Results: The total effective rate was 85.0% in the treatment group and 70.0% in the control group, with significant difference between the two groups (P <0.05). The comparison of the urine routine and laboratory indexes between the two groups before and after treatment and treatment The difference between the two groups was statistically significant (P <0.05, P <0.01). Conclusion: Shenyinkang tablets combined with chordensan potassium treatment of IgA nephropathy has a good effect.